Rhinomed Limited (ASX:RNO) is pleased to announce today that it has raised a total of A$2.5m by a way of a placement of 78,125,000 fully paid ordinary shares at A$0.032 per shares with institutional, Sophisticated, and Offshore investors (placement).
Australian respiratory technology company, Rhinomed (ASX:RNO) is pleased to announce it has entered into a landmark partnership with SleepGP, a growing network of GP practices, to raise awareness of sleep disordered breathing issues within the family medicine setting.
Compumedics Limited (ASX:CMP) ("Compumedics" and "Company") is pleased to announce that it has secured a new three-year contract, for the distribution of Compumedics' Neuroscan Brain Research and neurology systems in South Korea with the Company's long-term distribution partner, Kwangwon.
iQ3Corp Ltd (ASX:iQ3) is pleased to announce the appointment of Mr. David Batista to head up the investment banking operations of its U.S. subsidiary, iQ Capital LLC, based in New York.
Compumedics Limited (ASX:CMP) is pleased to announce that it has secured a $600,000 order to fit out the neurology department at the new Perth Children's Hospital, which is currently under construction.
Rhinomed Ltd (ASX:RNO) has been building its international presence and connections amongst the international investment and pharmaceutical community this year. In March, Michael Johnson was the keynote 'Rising Star' presentation at the Master Investor Show in London.
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today reported its 2015 financial results and business update. During the year, the company made significant progress on the development of its portfolio of cellbased therapies for the treatment of osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases for the human and animal health markets.
